Contact information
Type
Scientific
Primary contact
Prof Philip Hazell
ORCID ID
Contact details
Locked Bag 1014
Wallsend
NSW
2287
Australia
Philip.Hazell@hnehealth.nsw.gov.au
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N/A
Study information
Scientific title
Acronym
Study hypothesis
Not provided at time of registration
Ethics approval
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Not specified
Trial type
Treatment
Patient information sheet
Condition
Self harm
Intervention
This trial aims to replicate Wood et al's (2001) study and continue evaluation of whether group psychotherapy is associated with decreased repetition of self harm in adolescents. Adolescents will be randomised to treatment as usual (TAU) or the group intervention (to be used in conjunction with TAU).
The experimental arm involves attendance at six group sessions run by local clinicians. Participants can continue attending the group for up to one year. The group psychotherapy is manualised and based on problem solving and cognitive behavioural therapy.
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measure
Outcome assessments will be conducted at baseline, seven weeks, six months and one year. Outcomes of interest include repetition of self harm, changes in diagnosis, level of depressive symptoms and level of suicidal ideation. Service use and repetition of self harm will be monitored monthly.
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/11/2004
Overall trial end date
31/01/2007
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
Adolescents (12-16 years) who present to one of three Australian child and youth mental health services and who report having engaged in two or more episodes of deliberate self harm in the past year are eligible to participate.
Deliberate self harm is defined as any intentional self inflicted injury, regardless of the apparent purpose of the act (includes suicidal and non suicidal behaviour).
Participant type
Patient
Age group
Child
Gender
Both
Target number of participants
Not provided at time of registration
Participant exclusion criteria
Acute psychosis, anorexia nervosa, intellectual delay, and inability to attend the intervention or research appointments.
Recruitment start date
01/11/2004
Recruitment end date
31/01/2007
Locations
Countries of recruitment
Australia
Trial participating centre
Locked Bag 1014
Wallsend, NSW
2287
Australia
Sponsor information
Organisation
American Foundation of Suicide Prevention
Sponsor details
120 Wall Street
22nd Floor
New York
10005
United States of America
+1 212 363 3500
inquiry@afsp.org
Sponsor type
Charity
Website
Funders
Funder type
Charity
Funder name
American Foundation for Suicide Prevention (USA)
Alternative name(s)
The American Foundation for Suicide Prevention, AFSP
Funding Body Type
private sector organisation
Funding Body Subtype
Trusts, charities, foundations (both public and private)
Location
United States of America
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Publication list